Refocus Group
Recent Finacing
Equity
Recent Raise
$15M
Refocus develops the VisAbility Micro-Insert System, a scleral implant placed via outpatient topical-anesthesia procedure inserting four micro-thin implants beneath the sclera to restore near vision without altering cornea or lens.
Highlights
Focus Areas
Biotechnology
Health Care
Medical Device
Recent Investors
Financials
$15M
Total Raised
1
Funding round
2
Investors